Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1995 1
1996 3
1997 10
1998 9
1999 10
2000 4
2001 5
2002 3
2003 3
2004 6
2005 3
2006 7
2007 8
2008 5
2009 4
2010 5
2011 12
2012 7
2013 7
2014 8
2015 6
2016 17
2017 19
2018 16
2019 12
2020 5
2021 11
2022 7
2023 3
2024 10
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Results by year

Filters applied: . Clear all
Page 1
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology.
Watts AJB, Keller KH, Lerner G, Rosales I, Collins AB, Sekulic M, Waikar SS, Chandraker A, Riella LV, Alexander MP, Troost JP, Chen J, Fermin D, Yee JL, Sampson MG, Beck LH Jr, Henderson JM, Greka A, Rennke HG, Weins A. Watts AJB, et al. Among authors: chandraker a. J Am Soc Nephrol. 2022 Jan;33(1):238-252. doi: 10.1681/ASN.2021060794. Epub 2021 Nov 3. J Am Soc Nephrol. 2022. PMID: 34732507 Free PMC article.
Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document.
Lefaucheur C, Louis K, Morris AB, Taupin JL, Nickerson P, Tambur AR, Gebel HM, Reed EF; STAR 2022 Working Group. Lefaucheur C, et al. Am J Transplant. 2023 Jan;23(1):115-132. doi: 10.1016/j.ajt.2022.11.013. Epub 2023 Jan 11. Am J Transplant. 2023. PMID: 36695614 Free article. Review.
Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements.
Raina R, Jothi S, Haffner D, Somers M, Filler G, Vasistha P, Chakraborty R, Shapiro R, Randhawa PS, Parekh R, Licht C, Bunchman T, Sethi S, Mangat G, Zaritsky J, Schaefer F, Warady B, Bartosh S, McCulloch M, Alhasan K, Swiatecka-Urban A, Smoyer WE, Chandraker A, Yap HK, Jha V, Bagga A, Radhakrishnan J. Raina R, et al. Among authors: chandraker a. Kidney Int. 2024 Mar;105(3):450-463. doi: 10.1016/j.kint.2023.10.017. Epub 2023 Dec 22. Kidney Int. 2024. PMID: 38142038 Review.
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.
Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. Zeisberg EM, et al. Among authors: chandraker a. Nat Med. 2007 Aug;13(8):952-61. doi: 10.1038/nm1613. Epub 2007 Jul 29. Nat Med. 2007. PMID: 17660828
A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody-Mediated Rejection.
Halleck F, Böhmig GA, Couzi L, Rostaing L, Einecke G, Lefaucheur C, Legendre C, Montgomery R, Hughes P, Chandraker A, Wyburn K, Halloran P, Maldonado AQ, Sjöholm K, Runström A, Lefèvre P, Tollemar J, Jordan S. Halleck F, et al. Among authors: chandraker a. Clin Transplant. 2024 Jul;38(7):e15383. doi: 10.1111/ctr.15383. Clin Transplant. 2024. PMID: 39023092 Clinical Trial.
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.
Hanna GJ, Dharanesswaran H, Giobbie-Hurder A, Harran JJ, Liao Z, Pai L, Tchekmedyian V, Ruiz ES, Waldman AH, Schmults CD, Riella LV, Lizotte P, Paweletz CP, Chandraker AK, Murakami N, Silk AW. Hanna GJ, et al. Among authors: chandraker ak. J Clin Oncol. 2024 Mar 20;42(9):1021-1030. doi: 10.1200/JCO.23.01498. Epub 2024 Jan 22. J Clin Oncol. 2024. PMID: 38252908 Free PMC article. Clinical Trial.
Immunologic monitoring in kidney transplant recipients.
Townamchai N, Safa K, Chandraker A. Townamchai N, et al. Among authors: chandraker a. Kidney Res Clin Pract. 2013 Jun;32(2):52-61. doi: 10.1016/j.krcp.2013.04.002. Epub 2013 May 29. Kidney Res Clin Pract. 2013. PMID: 26877913 Free PMC article. Review.
Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Chandraker A, Regmi A, Gohh R, Sharma A, Woodle ES, Ansari MJ, Nair V, Chen LX, Alhamad T, Norman S, Cibrik D, Singh M, Alper A, Jain D, Zaky Z, Knechtle S, Sharfuddin A, Gupta G, Lonze BE, Young JH, Adey D, Faravardeh A, Dadhania DM, Rossi AP, Florescu D, Cardarelli F, Ma J, Gilmore S, Vasileiou S, Jindra PT, Wojciechowski D. Chandraker A, et al. J Am Soc Nephrol. 2024 May 1;35(5):618-629. doi: 10.1681/ASN.0000000000000329. Epub 2024 Mar 12. J Am Soc Nephrol. 2024. PMID: 38470444 Clinical Trial.
Novel Targets of Immunosuppression in Transplantation.
Shin HS, Grgic I, Chandraker A. Shin HS, et al. Among authors: chandraker a. Clin Lab Med. 2019 Mar;39(1):157-169. doi: 10.1016/j.cll.2018.10.008. Epub 2018 Dec 18. Clin Lab Med. 2019. PMID: 30709504 Review.
215 results